C.D.C. Warns the New Virus Variant Could Fuel Huge Spikes in Covid-19 Cases
The more contagious version, first identified in Britain, is expected to spread widely and lead to further strains on an already overburdened health care system.
Related Articles
Trump Demands a Cut of Donations From Campaigns That Use His Name
The Trump campaign said that candidates using his brand should turn over at least 5 percent of donations and encouraged them to send more than…
Is There a Cure for I.B.S.?
Here’s what experts do (and don’t) know about this perplexing condition.
Women Talk Through Their Abortions on TikTok
At a time of heightened confusion and legal battles over access to abortion, women are looking to social media for answers.
How to Turn a Bike Ride Into a Bike Workout
Cycling isn’t just fun. It can also deliver big fitness gains with the right gear and strategy.
In Australia, ‘Cats Are Just Catastrophic’
Feral cats take a heavy toll on the world’s wildlife, especially Down Under. The solution? Smarter traps, survival training for prey species, and the “Felixer.”
U.S. to Limit Deadly Mining Dust as Black Lung Resurges
Federal regulation capping toxic airborne silica has been decades in the making. The delay has cost miners dearly.
Interior Said to Reject Industrial Road Through Alaskan Wilderness
A mining company wants to build a 211-mile industrial road through Alaskan wilderness to reach a large copper deposit. The Interior Department says it would…
5 Takeaways From a Year of Medicaid Upheaval
In the year after a pandemic-era policy preserving Medicaid coverage lapsed, more than 20 million people were dropped from the program at some point.
Sleep Apnea Reduced in People Who Took Weight-Loss Drug, Eli Lilly Reports
The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s Wegovy.
Sleep Apnea Reduced in People Who Took Weight-Loss Drug, Eli Lilly Reports
The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s Wegovy.